Clinical Trials Browser

Melanoma × Infliximab × 90 days × Clear all

NCT07619898 2026-06-02

PHOENIX-ECP

Phase 2 Not yet recruiting

Colitis, Hepatitis, Melanoma

NCT05034536 2026-05-18

PD-1 Antibody Therapy + Infliximab for Metastatic Melanoma

Phase 2 Active not recruiting

Melanoma